Claudia Ulbrich, Cardior ЁЯЗйЁЯЗк | Being the Founder of a Rare тВм1B Exit | E15
Manage episode 417018188 series 3470295
WeтАЩre in Hannover ЁЯЗйЁЯЗк with the founder and CEO of Cardior, Claudia Ulbrich
We talked about CardiorтАЩs recent тВм1B exit to Novo Nordisk. We also talk about miRNA and Cardiovascular, and why she earned the funny nickname тАЬFrau BiotechтАЭ.
ЁЯТО ABOUT THE SPEAKER
Claudia has been founding biotechs since the тАЩ90s. She founded her first biotech company, LipoNova AG in 1998 and went on to co-found many more, including Cardior Pharmaceuticals. During her time she has launched and brought public a cancer vaccine company, helped see through a multi-million dollar deal of over тВм20M, and much more.
ЁЯФЧ LINKS MENTIONED
- Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease: https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=167038
ЁЯУЬ TRANSCRIPT
Read the full transcript here:
ЁЯл╢ FOLLOW US
- Newsletter: http://eepurl.com/h_fnmH
- LinkedIn: https://www.linkedin.com/company/flot-bio/
ЁЯОЩя╕П ABOUT FLOT.BIO
Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 15k monthly views. Free.
тнРя╕П SPONSORSHIP
Ready to amplify your brand to influential leaders in biotech and biopharma? Contact nick@flot.bio and unlock sponsorship opportunities in our podcasts!
ЁЯЩП LIKE/FOLLOW/REVIEW
Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.
тП░ TIMESTAMPS
[00:00:00] Intro
[00:01:47] Novo Nordisk deal
[00:10:19] Results from heart disease phase1
[00:19:55] MicroRNA
[00:26:42] The history of Cardior
[00:41:49] Working with Centerview
[00:45:17] Frau Biotech
[00:53:57] Thanks for listening
16 рдПрдкрд┐рд╕реЛрдбрд╕